EVP, Research & CSO of Vir Biotechnology Inc (30-Year Financial, Insider Trades) Herbert Virgin (insider trades) sold 14,920 shares of VIR on 06/24/2020 at an average price of $44.64 a share. The total sale was $666,029.
Vir Biotechnology Inc has a market cap of $5.64 billion; its shares were traded at around $47.86 with and P/S ratio of 509.13. GuruFocus has detected 1 severe warning sign with Vir Biotechnology Inc. .
CFO Recent Trades:
- CFO Howard Horn sold 10,000 shares of VIR stock on 06/19/2020 at the average price of $40. The price of the stock has increased by 19.65% since.
- CFO Howard Horn sold 10,000 shares of VIR stock on 06/01/2020 at the average price of $35.1. The price of the stock has increased by 36.35% since.
Directors and Officers Recent Trades:
- EVP, Research & CSO Herbert Virgin sold 14,920 shares of VIR stock on 06/24/2020 at the average price of $44.64. The price of the stock has increased by 7.21% since.
- EVP, Research & CSO Herbert Virgin sold 3,510 shares of VIR stock on 06/19/2020 at the average price of $38. The price of the stock has increased by 25.95% since.
- Chief Medical Officer Phillip Pang sold 12,500 shares of VIR stock on 06/17/2020 at the average price of $37.27. The price of the stock has increased by 28.41% since.
- EVP, Research & CSO Herbert Virgin sold 3,805 shares of VIR stock on 06/09/2020 at the average price of $36.28. The price of the stock has increased by 31.92% since.
- Chief Medical Officer Phillip Pang sold 12,500 shares of VIR stock on 06/03/2020 at the average price of $35.07. The price of the stock has increased by 36.47% since.
For the complete insider trading history of VIR, click here
.
